Portal hypertension symptoms and treatment, portal hypertension - Hungarian translation – Linguee
Tornai, István Absztrakt: Portal hypertension defined as an abnormally high pressure in hepatic PV, which clinically described as a venous pressure gradient of 10 mmHg or more. Based on anatomical location, portal hypertension is classified as prehepatic, intrahepatic and posthepatic.
PPH is an rare illness in which augmented portal pressure is triggered by impediment of the portal venous tree before it moves in the liver. Többet Portal hypertension defined as an abnormally high pressure in hepatic PV, which clinically described as a venous pressure gradient of 10 mmHg or more.
Congenital abnormalities, prothrombotic conditions and other causal illnesses that disturb part or all of the vessels of partal venous system are the leading cause of obstruction. Symptoms always depend on the beginning and the degree of the thrombosis and the expansion of collateral circulation.
In case of acute PVT the typical manifestations of the disease are intestinal congestion and ischemia. The main stream of patients display splenomegaly, but ascites is infrequent.
In patients with chronic PVT, the symptoms include gastrointestinal bleeding, splenomegaly and hypersplenism. In cirrhotic patients with PVT, all of the standard manifestations of portal hypertension such as ascites, varices and hepatic encephalopathy are present.
Portal hypertension - cuases, symptoms, diagnosis, investigations, / portal hypertension in hindi
The goal of the treatment is to correct the underlying elements, stoppage of thrombosis extension, and attainment of PV patency. Variceal treatment include, pre-primary prophylaxis: patient with portal hypertension who has not yet developed varices and the aim is to prevent varices; 2 primary prophylaxis: the patient with gastroesophageal varices who has never had portal hypertension symptoms and treatment from varices and the aim is to prevent bleeding; 3 secondary prophylaxis: the patient with acute variceal bleeding and the aim is to stop the bleeding and prevent its early and late reccurance.
Among others the most frequent are the psychiatric symptoms. These symptoms are also the most frequent reasons of non-compliance and early cessation of treatment which can be avoided with rapid recognition and adequate treatment. Therefore, the early recognition of the psychiatric symptoms is of high importance. They also present the evaluation method for the questionnaire, which makes the evaluation of the data easier for non-psychiatrist doctors as well. Between September and July all interferon treated patients who also had psychiatric consultation filled in the questionnaire.